Announced Thu, 3 Sept · 23:46 IST
Board approves 51% stake acquisition in Matrix Labs via share swap
ONEGLOBAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹527.15
prior close
₹547.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.1-0.1-0.4+0.9+2.6+3.4+2.8-1.1————
Up moveDown movePending
AI summary
Board approved acquiring 51% stake each in Matrix Labs Diagnocare (FY25 turnover Rs 171.30 Cr) and Matrix Labs Pvt Ltd (Rs 8.92 Cr) via share swap. Will allot 7,15,040 equity shares at Rs 553 each (total about Rs 39.54 Cr) to selling shareholders. Also increased authorised capital from Rs 25.05 Cr to Rs 50 Cr, reappointed statutory auditors and appointed new internal auditors. 34th AGM set for Sept 29, 2026.
Likely market impact
Diversifies into healthcare and diagnostics via share swap. Will dilute existing shareholders and make both targets subsidiaries pending approvals.